KDR genetic predictor of toxicities induced by sorafenib and regorafenib
- Citation:
- Pharmacogenomics J vol 22 (5-6) 251-7
- Year:
- 2022
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 12
- Parents:
- 3546
- Children:
- None
- Pharmas:
- Bayer Healthcare/Berlex
- Grants:
- U10CA180821, U10CA180882, U24 CA196171, UG1CA233373, UG1CA233290
- Corr. Author:
- Authors:
- Julia C. F. Quintanilha Susan Geyer Amy S. Etheridge Alessandro Racioppi Kelli Hammond Daniel J. Crona Carol E. Peña Sawyer Jacobson Federica Marmorino Daniele Rossini Chiara Cremolini Hanna K. Sanoff Ghassan K. Abou-Alfa Federico Innocenti
- Networks:
- LAPS-NC007, LAPS-NY016
- Study
- CALGB-80802
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: